Secretory leukocyte proteinase inhibitor-competent DNA deposits are potent stimulators of plasmacytoid dendritic cells: Implication for psoriasis

Journal of Immunology

Volumn 189, Issue 4, 2012, Pages 1611-1617

  Skrzeczynska Moncznik, Joanna ^a   Wlodarczyk, Agnieszka ^a   Zabieglo, Katarzyna ^a   Kapinska Mrowiecka, Monika ^b   Marewicz, Ewa ^a   Dubin, Adam ^a   Potempa, Jan ^a,c   Cichy, Joanna ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b Zeromski Specialist Hospital   (Poland)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INTERFERON; LEUKOCYTE ELASTASE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TOLL LIKE RECEPTOR 9;

ADULT; ARTICLE; CELL ACTIVATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATION; MALE; NEUTROPHIL; NEUTROPHIL EXTRACELLULAR TRAP; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSORIASIS; SKIN BIOPSY; SKIN DEFECT; WOUND HEALING;

ADULT; DENDRITIC CELLS; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE I; LEUKOCYTE ELASTASE; MALE; PSORIASIS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR;

EID: 84864817766     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103293     Document Type: Article

References (41)

1. Doumas, S., A. Kolokotronis, and P. Stefanopoulos. 2005. Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor. Infect. Immun. 73: 1271-1274. (Pubitemid 40470711)
2. Jacobsen, L. C., O. E. Sørensen, J. B. Cowland, N. Borregaard, and K. Theilgaard-Mönch. 2008. The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils. J. Leukoc. Biol. 83: 1155-1164. (Pubitemid 351960347)
3. Jin, F. Y., C. Nathan, D. Radzioch, and A. Ding. 1997. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 88: 417-426. (Pubitemid 27131383)
4. Sallenave, J. M., M. Si Tahar, G. Cox, M. Chignard, and J. Gauldie. 1997. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J. Leukoc. Biol. 61: 695-702. (Pubitemid 27276061)
5. Wingens, M., B. H. van Bergen, P. S. Hiemstra, J. F. Meis, I. M. van Vlijmen-Willems, P. L. Zeeuwen, J. Mulder, H. A. Kramps, F. van Ruissen, and J. Schalkwijk. 1998. Induction of SLPI (ALP/HUSI-I) in epidermal keratinocytes. J. Invest. Dermatol. 111: 996-1002. (Pubitemid 29115165)
6. Reardon, C., M. Lechmann, A. Brüstle, M. G. Gareau, N. Shuman, D. Philpott, S. F. Ziegler, and T. W. Mak. 2011. Thymic stromal lymphopoetin-induced expression of the endogenous inhibitory enzyme SLPI mediates recovery from colonic inflammation. Immunity 35: 223-235.
7. Zhu, J., C. Nathan, W. Jin, D. Sim, G. S. Ashcroft, S. M. Wahl, L. Lacomis, H. Erdjument-Bromage, P. Tempst, C. D. Wright, et al. 2002. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 111: 867-878. (Pubitemid 36106407)
8. Taggart, C. C., S. A. Cryan, S. Weldon, A. Gibbons, C. M. Greene, E. Kelly, T. B. Low, S. J. O'neill, and N. G. McElvaney. 2005. Secretory leucoprotease inhibitor binds to NF-kB binding sites in monocytes and inhibits p65 binding. J. Exp. Med. 202: 1659-1668. (Pubitemid 41815872)
9. Xu, W., B. He, A. Chiu, A. Chadburn, M. Shan, M. Buldys, A. Ding, D. M. Knowles, P. A. Santini, and A. Cerutti. 2007. Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat. Immunol. 8: 294-303. (Pubitemid 46745379)
10. Subramaniyam, D., C. Hollander, U. Westin, J. Erjefält, T. Stevens, and S. Janciauskiene. 2011. Secretory leukocyte protease inhibitor inhibits neutrophil apoptosis. Respirology 16: 300-307.
11. Remold-O'Donnell, E., J. C. Nixon, and R. M. Rose. 1989. Elastase inhibitor: characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils. J. Exp. Med. 169: 1071-1086. (Pubitemid 19085841)
12. Faurschou, M., and N. Borregaard. 2003. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5: 1317-1327. (Pubitemid 37410245)
13. Fuchs, T. A., U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, V. Wahn, Y.Weinrauch, V. Brinkmann, and A. Zychlinsky. 2007. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176: 231-241. (Pubitemid 46143263)
14. Papayannopoulos, V., K. D. Metzler, A. Hakkim, and A. Zychlinsky. 2010. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell Biol. 191: 677-691.
15. Mantovani, A., M. A. Cassatella, C. Costantini, and S. Jaillon. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11: 519-531.
16. Pinkus, H., and A. H. Mehregan. 1966. The primary histologic lesion of seborrheic dermatitis and psoriasis. J. Invest. Dermatol. 46: 109-116.
17. Garcia-Romo, G. S., S. Caielli, B. Vega, J. Connolly, F. Allantaz, Z. Xu, M. Punaro, J. Baisch, C. Guiducci, R. L. Coffman, et al. 2011. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3: 73ra20.
18. Hakkim, A., B. G. Fürnrohr, K. Amann, B. Laube, U. A. Abed, V. Brinkmann, M. Herrmann, R. E. Voll, and A. Zychlinsky. 2010. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. USA 107: 9813-9818.
19. Kessenbrock, K., M. Krumbholz, U. Schönermarck, W. Back, W. L. Gross, Z. Werb, H. J. Gröne, V. Brinkmann, and D. E. Jenne. 2009. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15: 623-625.
20. Lande, R., D. Ganguly, V. Facchinetti, L. Frasca, C. Conrad, J. Gregorio, S. Meller, G. Chamilos, R. Sebasigari, V. Riccieri, et al. 2011. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3: 73ra19.
21. Lande, R., J. Gregorio, V. Facchinetti, B. Chatterjee, Y. H. Wang, B. Homey, W. Cao, Y. H.Wang, B. Su, F. O. Nestle, et al. 2007. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449: 564-569. (Pubitemid 47525141)
22. Nestle, F. O., C. Conrad, A. Tun-Kyi, B. Homey, M. Gombert, O. Boyman, G. Burg, Y. J. Liu, and M. Gilliet. 2005. Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J. Exp. Med. 202: 135-143. (Pubitemid 41002916)
23. Blasius, A. L., and B. Beutler. 2010. Intracellular Toll-like receptors. Immunity 32: 305-315.
24. Liu, Y. J. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23: 275-306.
25. Sørensen, O., K. Arnljots, J. B. Cowland, D. F. Bainton, and N. Borregaard. 1997. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90: 2796-2803. (Pubitemid 27413490)
26. Sørensen, O. E., P. Follin, A. H. Johnsen, J. Calafat, G. S. Tjabringa, P. S. Hiemstra, and N. Borregaard. 2001. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97: 3951-3959.
27. Baugh, R. J., and J. Travis. 1976. Human leukocyte granule elastase: rapid isolation and characterization. Biochemistry 15: 836-841.
28. Chase, T. J., and E. S. Show. 1970. Titration of trypsin, plasmin and trombin with p-nitrophenyl-p′-guanidinobenzoate HCl. Methods Enzymol. 19: 20-27.
29. Travis, J., and G. S. Salvesen. 1983. Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52: 655-709. (Pubitemid 13030691)
30. Boudier, C., and J. G. Bieth. 1994. Oxidized mucus proteinase inhibitor: a fairly potent neutrophil elastase inhibitor. Biochem. J. 303: 61-68. (Pubitemid 24302900)
31. Nobar, S. M., M. L. Zani, C. Boudier, T. Moreau, and J. G. Bieth. 2005. Oxidized elafin and trappin poorly inhibit the elastolytic activity of neutrophil elastase and proteinase 3. FEBS J. 272: 5883-5893. (Pubitemid 41689360)
32. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1982. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
33. Lin, A. M., C. J. Rubin, R. Khandpur, J. Y. Wang, M. Riblett, S. Yalavarthi, E. C. Villanueva, P. Shah, M. J. Kaplan, and A. T. Bruce. 2011. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J. Immunol. 187: 490-500.
34. Morgan, J. G., T. Sukiennicki, H. A. Pereira, J. K. Spitznagel, M. E. Guerra, and J. W. Larrick. 1991. Cloning of the cDNA for the serine protease homolog CAP37/azurocidin, a microbicidal and chemotactic protein from human granulocytes. J. Immunol. 147: 3210-3214.
35. Cichy, J., J. Potempa, and J. Travis. 1997. Biosynthesis of a1-proteinase inhibitor by human lung-derived epithelial cells. J. Biol. Chem. 272: 8250-8255. (Pubitemid 27147779)
36. Gregorio, J., S. Meller, C. Conrad, A. Di Nardo, B. Homey, A. Lauerma, N. Arai, R. L. Gallo, J. Digiovanni, and M. Gilliet. 2010. Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J. Exp. Med. 207: 2921-2930.
37. Fäh, J., J. Pavlovic, and G. Burg. 1995. Expression of MxA protein in inflammatory dermatoses. J. Histochem. Cytochem. 43: 47-52.
38. van der Fits, L., L. I. van der Wel, J. D. Laman, E. P. Prens, and M. C. Verschuren. 2004. In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-α sensitivity is unaltered. J. Invest. Dermatol. 122: 51-60.
39. Downs, A. M., and M. G. Dunnill. 2000. Exacerbation of psoriasis by interferon-α therapy for hepatitis C. Clin. Exp. Dermatol. 25: 351-352. (Pubitemid 30670597)
40. Ketikoglou, I., S. Karatapanis, I. Elefsiniotis, G. Kafiri, and A. Moulakakis. 2005. Extensive psoriasis induced by pegylated interferon α-2b treatment for chronic hepatitis B. Eur. J. Dermatol. 15: 107-109. (Pubitemid 40434638)
41. Ashcroft, G. S., K. Lei, W. Jin, G. Longenecker, A. B. Kulkarni, T. Greenwell-Wild, H. Hale-Donze, G. McGrady, X. Y. Song, and S. M. Wahl. 2000. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat. Med. 6: 1147-1153.